About Us
Our Mission
A patient’s health merits much more than just standard practice and prescription.
We believe that every patient should have access to the highest recommended therapies for their needs and that when patients are prescribed the best available therapies, they achieve the best clinical outcomes.
At CoveredMeds our mission is to enable clinicians to identify and prescribe the very best therapies available to their patients to ensure they get the best outcomes possible.
Our History
Our Beginning
Since its start in 2019, CoveredMeds has been committed to providing innovative help to clinicians. At first, the CoveredMeds platform only offered formulary determinations for 15 insurance plans and for only one indication, diabetes. In 2020 we added asthma and COPD and had grown to over 100 insurance formularies that we monitored and updated for our clients on a monthly basis.
In 2021 we invested in a data stream that brought us access to every insurance formulary in the country in real time allowing us to scale as we continued to grow. We also completely redesigned our interface to utilize the data we were receiving and added four psychiatric indications, schizophrenia, bipolar disorder, depression, and ADD/ADHD.
In 2022, we expanded from 7 indications and 350 drugs to over 40 indications and 4,000 drugs, now essentially offering the coverage determination for every indication, every medication, and every formulary. We also added the ability to see step therapy and prior authorization requirements for medications enabling clinicians to know exactly what a restricted drug will require to get it covered, before they even decide to prescribe it.
Our Future
Our top two technical enhancements that we are working on are to have a true interface with EMR platforms that will auto select an indication and insurance plan for our users, and we will be developing a mobile app that delivers the same function, making it more accessible to individual licensees.
We also are working to multiply our growth and partner with other service providers in the 340B industry, large private healthcare companies, and individual clinicians. This all is to fulfill our mission of helping clinicians help patients.
Our Leadership
Byron E. Jones, PharmD, Founder & CEO
As Founder and CEO of CoveredMeds, Dr. Byron Jones, PharmD, is a leader dedicated to improving the healthcare industry. In 2019 he founded CoveredMeds, LLC, in hopes to guide clinicians to the highest recommended, covered therapies available to their patients.
Before founding CoveredMeds, Dr. Jones spent 11 years with Target Pharmacy, where he spent his first 2 years as a Pharmacist on the bench but then was asked to work at Targets headquarters where he worked to update best practices, developed and implemented a pharmacist administered vaccination program, and was a primary business user consultant on the development of their proprietary dispensing software. In 2008, he was named Pharmacist of the Year by Target and was later promoted to Pharmacy Business Partner, overseeing 32 Target stores in Southern California.
In 2015 Dr. Jones joined La Maestra Community Health Centers as their Director of Pharmacy. There, Dr. Jones developed one of the most innovative in-house pharmacy networks in the country by developing strong provider-pharmacist relationships, implementing multiple therapeutic protocols, and inventing/investing in new technologies. Dr. Jones led their pharmacy department to an 80% capture rate, opened 2 additional in-house pharmacies, and increased the clinic’s 340B savings dramatically. He also led them to become the first clinic in the country to partner with Mellitus Health to provide patients with cutting-edge insulin dosing services.
Dr. Jones has been a featured speaker at NACHC’s CHI/EXPO and FOM/IT conferences in Chicago and Las Vegas, has presented to the Alaska State Board of Pharmacy on TelePharmacy, was a featured speaker at the 340B Coalition Winter Conference in 2018 and at McKesson’s IdeaShare in 2019, is a 340B Apexus Certified Expert, and was named by PharmacyTimes and Parata as a Finalist for the Next Generation Pharmacist Award in Technology and Innovation in October 2018.
Dr. Jones received studied chemistry at Brigham Young University and earned his Doctor of Pharmacy degree from Idaho State University College of Pharmacy in 2004.
Our Mission
A patient’s health merits much more than just standard practice and prescription.
We believe that every patient should have access to the highest recommended therapies for their needs and that when patients are prescribed the best available therapies, they achieve the best clinical outcomes.
At CoveredMeds our mission is to enable clinicians to identify and prescribe the very best therapies available to their patients to ensure they get the best outcomes possible.
About Us
Our Leadership
Byron E. Jones, PharmD, Founder & CEO
As Founder and CEO of CoveredMeds, Dr. Byron Jones, PharmD, is a leader dedicated to improving the healthcare industry. In 2019 he founded CoveredMeds, LLC, in hopes to guide clinicians to the highest recommended, covered therapies available to their patients.
Before founding CoveredMeds, Dr. Jones spent 11 years with Target Pharmacy, where he spent his first 2 years as a Pharmacist on the bench but then was asked to work at Targets headquarters where he worked to update best practices, developed and implemented a pharmacist administered vaccination program, and was a primary business user consultant on the development of their proprietary dispensing software. In 2008, he was named Pharmacist of the Year by Target and was later promoted to Pharmacy Business Partner, overseeing 32 Target stores in Southern California.
In 2015 Dr. Jones joined La Maestra Community Health Centers as their Director of Pharmacy. There, Dr. Jones developed one of the most innovative in-house pharmacy networks in the country by developing strong provider-pharmacist relationships, implementing multiple therapeutic protocols, and inventing/investing in new technologies. Dr. Jones led their pharmacy department to an 80% capture rate, opened 2 additional in-house pharmacies, and increased the clinic’s 340B savings dramatically. He also led them to become the first clinic in the country to partner with Mellitus Health to provide patients with cutting-edge insulin dosing services.
Dr. Jones has been a featured speaker at NACHC’s CHI/EXPO and FOM/IT conferences in Chicago and Las Vegas, has presented to the Alaska State Board of Pharmacy on TelePharmacy, was a featured speaker at the 340B Coalition Winter Conference in 2018 and at McKesson’s IdeaShare in 2019, is a 340B Apexus Certified Expert, and was named by PharmacyTimes and Parata as a Finalist for the Next Generation Pharmacist Award in Technology and Innovation in October 2018.
Dr. Jones received studied chemistry at Brigham Young University and earned his Doctor of Pharmacy degree from Idaho State University College of Pharmacy in 2004.